17:03 EST Verastem files $300M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VSTM:
- Verastem reports Q3 adjusted EPS (71c), consensus (84c)
- Verastem announces results from avutometinib, defactinib trial at IGCS 2023
- Verastem announces initial results of RAMP 203 trial of avutometinib, LUMAKRAS
- Verastem presents avutometinib and defactinib combination program updates
- Verastem initiated with a Buy at B. Riley